Trial Profile
Systemic thrombolysis with Alteplase between 3-4.5 hours in acute ischaemic stroke. Evaluation of clinical efficacy
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 17 Jun 2014
Price :
$35
*
At a glance
- Drugs Alteplase (Primary)
- Indications Stroke
- Focus Therapeutic Use
- 17 Jun 2014 New trial record